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Background: It has not been known about the association between plaque components and neointimal hyperplasia in patients who underwent 
drug-eluting stent (DES) implantation. Virtual histology-intravascular ultrasound (VH-IVUS) can provide quantitative information on plaque 
components.
Methods: We used VH-IVUS to evaluate the relation between neointimal hyperplasia and plaque components in 129 lesions in 102 patients who 
underwent DES implantation (65 paclitaxel eluting stent, 27 sirolimus eluting stents, 28 zotarolimus eluting stents, 9 other drug-eluting stents). We 
compared the VH-IVUS parameters between 19 in-stent restenosis (ISR) lesions and 110 non-ISR lesions. VH-IVUS classified the color-coded tissue 
into four major components: fibrotic (FT), fibro-fatty (FF), dense calcium (DC), and necrotic core (NC).
Results: ISR group was more diabetics (50% vs. 33%, p=0.050) and higher glucose level compared non-ISR group (173±57 mg/dl vs. 143±40 
mg/dl, p=0.036). There were no significant differences in target vessel and ACC/AHA lesion type between ISR and non-ISR groups. There were no 
significant differences in lesion site external elastic membrane (13.9±3.1 mm2 vs. 14.7±5.5 mm2) and plaque plus media areas (3.9±0.7 mm2 
vs. 4.0±1.4 mm2) between ISR and non-ISR groups. There were no significant differences in relative plaque components at the minimum lumen 
site (FT: 56.7±16.8% vs. 59.0±13.7%, FF: 6.3±5.1% vs. 11.5±9.8%, DC: 13.3±9.9% vs. 9.3±8.3%, NC: 23.7±12.9% vs. 20.1±11.9%) and relative 
volumetric plaque components (FT: 57.5±11.9% vs. 58.7±10.9%, FF: 10.1±6.4% vs. 12.0±8.1%, DC: 12.4±6.8% vs. 10.9±6.8%, NC: 20.3±10.6% vs. 
18.5±9.4%) between ISR and non-ISR groups. There were no correlations between follow-up %neointima volume and volumetric plaque components 
(%FT: r=-0.002, p=0.990, %FF: r=0.187, p=0.175. %DC: r=-0.014, p=0.920, %NC: r=-0.123, p=0.376).
Conclusions: There was no relation between plaque components assessed by VH-IVUS and neointimal hyperplasia after DES implantation. Plaque 
components may affect plaque vulnerability at the initial clinical presentation, but not affect long-term clinical outcome.
